MedTrace Logo

A Real-world Study of Nitric Oxide Generator and Delivery System

NCT05703191 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2025-02-19

No results posted yet for this study

Summary

The study is aimed to observe the efficacy and safety of Nitric Oxide Generator and Delivery System in Pulmonary Hypertension of Newborn in real clinical settings.

Conditions

  • Pulmonary Hypertension of Newborn

Interventions

DEVICE

Nitric Oxide Generator and Delivery System

Initial at 20ppm is recommended by guidelines. The concentration is adjusted based on actual condition of subjects.

Sponsors & Collaborators

  • Novlead Inc.

    lead INDUSTRY

Principal Investigators

  • Bin Wang · Southern Medical University, China

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2025-03-31
Completion
2025-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05703191 on ClinicalTrials.gov